文献速递眼底病与葡萄膜炎

新加坡与加拿大不同族群新生血管性年龄相关性黄斑变性与息肉状脉络膜血管病变表型及治疗结局差异

Variations in Neovascular Age-Related Macular Degeneration and Polypoidal Choroidal Vasculopathy Phenotypes and Treatment Outcomes Across Singaporean, Canadian Asian, and Canadian Caucasian Populations.
PubMed 文献 · Am J Ophthalmol · 2026-08-14

该回顾性多中心比较研究纳入327例未治疗的新生血管性年龄相关性黄斑变性(nAMD)患者,比较新加坡亚裔、加拿大亚裔与加拿大白种人族群的息肉状脉络膜血管病变(PCV)特征、治疗模式及1年结局。结果显示新加坡亚裔(42.5%)与加拿大亚裔(42.1%)的PCV患病率相似且均显著高于加拿大白种人(13.5%,P < .01),PCV的OCT特征在各族群间一致,而治疗模式因医疗体系而异。

要点

  • 亚裔人群PCV患病率显著高于白种人,且不受地理位置影响,支持遗传基础。
  • 基于OCT的诊断标准可在不同族群中一致识别PCV特征。
  • 加拿大以贝伐珠单抗治疗为主,新加坡治疗药物多样且31.1%使用光动力疗法。

核心结论

  • PCV患病率的族群差异持续存在且与地理位置无关,支持遗传易感性。
  • PCV的OCT特征在各族群间一致。
  • 治疗模式在不同医疗体系间差异显著。

研究设计与样本

  • 回顾性、多中心、比较性研究。
  • 共纳入327例未治疗nAMD患者:新加坡国家眼科中心181例,加拿大温哥华146例(白种人89例,亚裔57例)。
  • 采用改良亚太眼成像学会基于OCT的非吲哚菁绿血管造影标准诊断PCV。

主要发现

  • 新加坡亚裔PCV患病率为42.5%,加拿大亚裔为42.1%,均显著高于加拿大白种人的13.5%(P < .01)。
  • PCV眼中OCT特征在各族群间一致:黄斑区为主(79.2%-83.3%)、双层征(83.3%-93.5%)、低软性玻璃膜疣患病率(4.2%-8.3%)、黄斑中心凹下脉络膜厚度>200 µm。
  • 加拿大PCV治疗以贝伐珠单抗为主(65.0%-70.0%),新加坡使用多种药物且光动力疗法占31.1%。
  • 新加坡PCV眼12个月最佳矫正视力(BCVA)改善(-0.22 logMAR,P < .01),典型nAMD三组BCVA均显著改善。

关键数值与推荐

  • PCV诊断采用改良亚太眼成像学会基于OCT的非吲哚菁绿血管造影标准:尖锐峰状色素上皮脱离和视网膜下色素上皮环状病变。

临床怎么用

  • 在无吲哚菁绿血管造影时,可采用基于OCT的无创标准识别PCV并进行跨族群比较。
  • PCV患病率存在族群差异,临床应对亚裔nAMD患者保持较高PCV怀疑。
  • 治疗模式受医疗体系影响,需结合可用药物和疗法制定个体化方案。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To compare the frequency of polypoidal choroidal vasculopathy (PCV) features, treatment patterns, and 1-year outcomes across Singaporean Asian, Canadian Asian, and Canadian Caucasian populations with neovascular age-related macular degeneration (nAMD) using optical coherence tomography (OCT)-based diagnostic criteria. DESIGN: Retrospective, multicenter, comparative study. PARTICIPANTS: A total of 327 treatment-naïve patients with nAMD: 181 from Singapore National Eye Centre and 146 from Vancouver, Canada (89 Caucasian, 57 Asian). METHODS: PCV was diagnosed using modified Asia-Pacific Ocular Imaging Society nonindocyanine green angiography OCT-based criteria (sharp-peaked pigment epithelial detachment and subretinal pigment epithelium ring-like lesion). Baseline OCT features, treatment patterns, and 12-month outcomes were compared across the three ethnic groups. MAIN OUTCOME MEASURES: PCV prevalence, OCT-based morphological features, treatment patterns, and change in best-corrected visual acuity (BCVA) at 12 months. RESULTS: PCV prevalence was similar between Singaporean Asian (42.5%) and Canadian Asian (42.1%) groups, both significantly higher than Canadian Caucasians (13.5%, P < .01). OCT features in PCV eyes were consistent across ethnic groups, including macular predominance (79.2%-83.3%), double-layer sign (83.3%-93.5%), low soft drusen prevalence (4.2%-8.3%), and subfoveal choroidal thickness >200 µm. Treatment patterns differed: bevacizumab predominated in Canada (65.0%-70.0% for PCV), while Singapore used varied agents, with photodynamic therapy in 31.1%. At 12 months, BCVA improved in Singaporean PCV eyes (-0.22 logMAR, P < .01). In typical nAMD, BCVA improved significantly across all three groups. CONCLUSIONS: Ethnic differences in PCV prevalence persist regardless of geographic location, supporting a predominant genetic basis for PCV susceptibility. OCT-based PCV features are consistent across ethnicities, while treatment patterns vary substantially between healthcare systems. Noninvasive OCT-based diagnostic criteria enable reliable cross-ethnic PCV comparison when indocyanine green angiography is unavailable.

来源:Am J Ophthalmol,查看原文。版权归原作者所有。

引用

  1. Huang A, Ling J, Gilead N, et al. Variations in Neovascular Age-Related Macular Degeneration and Polypoidal Choroidal Vasculopathy Phenotypes and Treatment Outcomes Across Singaporean, Canadian Asian, and Canadian Caucasian Populations. Am J Ophthalmol. 2026. PMID: 42600888. doi:10.1016/j.ajo.2026.08.018

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。